IR@PKUHSC  > 北京大学第二临床医学院  > 重症医学科
学科主题临床医学
Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice
Li Shu; Zhu Feng-xue; Zhang Hong-bin; Li Hui; An You-zhong
关键词liver ischemia/reperfusion T helper lymphocyte interleukin-33
刊名CHINESE MEDICAL JOURNAL
2013-05-20
DOI10.3760/cma.j.issn.0366-6999.20123530
126期:10页:1855-1859
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]REPERFUSION INJURY ; NKT CELLS ; LIVER ; IL-33 ; HEPATOCYTES ; ISCHEMIA ; PROTECTS ; RECEPTOR ; INNATE ; MOUSE
英文摘要

Background Interleukin (IL)-33 is a recently identified member of the IL-1 family that binds to the receptor, ST2L. This study examined IL-33 production in mouse liver and investigated its role in hepatic ischemia/reperfusion (I/R) injury.

Methods Male BALB/c mice ((22 +/- 3) g) were subjected to 90 minutes partial hepatic ischemia, followed by 6 hours reperfusion. First, mice were randomized into two groups: control group (laparotomy only, without blocking blood supply) and ischennia model group. IL-33 mRNA and serum protein levels were measured at 30, 60, 90 minutes after ischemia and 2 and 6 hours after reperfusion. Second, mice were randomized into four groups: control, model (injection of rabbit IgG polyclonal antibody), recombinant IL-33 intervention and anti-ST2L antibody intervention group. Mice were sacrificed 6 hours after reperfusion. Liver pathology was observed via transmission electron microscopy. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), IL-4, IL-5, IL-13, interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) levels were measured.

Results Levels of IL-33 mRNA and protein did not change during ischemia (P > 0.05) but increased significantly during reperfusion (P < 0.05). After reperfusion for 6 hours, serum levels of ALT, AST, IL-4, IL-5, IL-13, IFN-gamma and TNF-alpha were significantly increased (P < 0.05), and hepatocellular ultrastructure was damaged. Pretreatment with IL-33 attenuated severity of liver damage compared with controls, but pretreatment with anti-ST2L antibody increased severity. Serum levels of IL-4, IL-5 and IL-13 protein increased whereas IFN-gamma decreased following IL-33 pretreatment. Pretreatment with anti-ST2L antibody significantly decreased serum IL-4, IL-5, IL-13 levels and increased serum IFN-gamma levels compared with controls (P < 0.05). There was no change in the level of TNF-alpha.

Conclusion IL-33 is produced systematically and locally in liver during I/R injury. Pretreatment with IL-33 is therapeutic for hepatic I/R injury, possibly via inducing a Th1 to Th2 shift.

语种英语
WOS记录号WOS:000319529200011
项目编号RDB2010-21
资助机构Peking University People&prime ; s Hospital Research and Development Funds
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58392
专题北京大学第二临床医学院_重症医学科
作者单位Peking Univ, Peoples Hosp, Dept Crit Care Med, Beijing 100044, Peoples R China
推荐引用方式
GB/T 7714
Li Shu,Zhu Feng-xue,Zhang Hong-bin,et al. Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice[J]. CHINESE MEDICAL JOURNAL,2013,126(10):1855-1859.
APA Li Shu,Zhu Feng-xue,Zhang Hong-bin,Li Hui,&An You-zhong.(2013).Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice.CHINESE MEDICAL JOURNAL,126(10),1855-1859.
MLA Li Shu,et al."Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice".CHINESE MEDICAL JOURNAL 126.10(2013):1855-1859.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li Shu]的文章
[Zhu Feng-xue]的文章
[Zhang Hong-bin]的文章
百度学术
百度学术中相似的文章
[Li Shu]的文章
[Zhu Feng-xue]的文章
[Zhang Hong-bin]的文章
必应学术
必应学术中相似的文章
[Li Shu]的文章
[Zhu Feng-xue]的文章
[Zhang Hong-bin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。